EP2384734A2 - Transparent facial treatment mask - Google Patents
Transparent facial treatment mask Download PDFInfo
- Publication number
- EP2384734A2 EP2384734A2 EP10252172A EP10252172A EP2384734A2 EP 2384734 A2 EP2384734 A2 EP 2384734A2 EP 10252172 A EP10252172 A EP 10252172A EP 10252172 A EP10252172 A EP 10252172A EP 2384734 A2 EP2384734 A2 EP 2384734A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- water
- facial mask
- insoluble substrate
- wetting agent
- gsm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000001815 facial effect Effects 0.000 title claims abstract description 76
- 239000000758 substrate Substances 0.000 claims abstract description 101
- 238000000034 method Methods 0.000 claims abstract description 19
- 239000000080 wetting agent Substances 0.000 claims description 56
- 239000002537 cosmetic Substances 0.000 claims description 6
- 239000000839 emulsion Substances 0.000 claims description 3
- 239000007764 o/w emulsion Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 description 40
- 239000000463 material Substances 0.000 description 30
- 229920000297 Rayon Polymers 0.000 description 29
- 239000000835 fiber Substances 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 25
- 239000002964 rayon Substances 0.000 description 21
- 230000008901 benefit Effects 0.000 description 19
- -1 polypropylene Polymers 0.000 description 19
- 239000007788 liquid Substances 0.000 description 16
- 239000000047 product Substances 0.000 description 15
- 239000000284 extract Substances 0.000 description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 13
- 101100269850 Caenorhabditis elegans mask-1 gene Proteins 0.000 description 13
- 230000000887 hydrating effect Effects 0.000 description 13
- 239000000203 mixture Substances 0.000 description 11
- 239000004743 Polypropylene Substances 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- 239000012071 phase Substances 0.000 description 10
- 229920001155 polypropylene Polymers 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- VYGQUTWHTHXGQB-FFHKNEKCSA-N retinyl palmitate Natural products CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 229940061720 alpha hydroxy acid Drugs 0.000 description 5
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000003094 microcapsule Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 229940108325 retinyl palmitate Drugs 0.000 description 5
- 235000019172 retinyl palmitate Nutrition 0.000 description 5
- 239000011769 retinyl palmitate Substances 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 150000001277 beta hydroxy acids Chemical class 0.000 description 4
- 210000001061 forehead Anatomy 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 235000010215 titanium dioxide Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 239000000058 anti acne agent Substances 0.000 description 3
- 229940124340 antiacne agent Drugs 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 239000003248 enzyme activator Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 229920000247 superabsorbent polymer Polymers 0.000 description 3
- 229920002994 synthetic fiber Polymers 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 229960004308 acetylcysteine Drugs 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 239000007854 depigmenting agent Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229910001651 emery Inorganic materials 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000002532 enzyme inhibitor Substances 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 150000002334 glycols Chemical class 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 150000001261 hydroxy acids Chemical class 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- 239000004530 micro-emulsion Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 235000021283 resveratrol Nutrition 0.000 description 2
- 229940016667 resveratrol Drugs 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 125000002640 tocopherol group Chemical class 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000005526 vasoconstrictor agent Substances 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- IZFHEQBZOYJLPK-SSDOTTSWSA-N (R)-dihydrolipoic acid Chemical compound OC(=O)CCCC[C@@H](S)CCS IZFHEQBZOYJLPK-SSDOTTSWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 1
- JZLWSRCQCPAUDP-UHFFFAOYSA-N 1,3,5-triazine-2,4,6-triamine;urea Chemical compound NC(N)=O.NC1=NC(N)=NC(N)=N1 JZLWSRCQCPAUDP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- 241000157282 Aesculus Species 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 229940123150 Chelating agent Drugs 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 240000000491 Corchorus aestuans Species 0.000 description 1
- 235000011777 Corchorus aestuans Nutrition 0.000 description 1
- 235000010862 Corchorus capsularis Nutrition 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010012444 Dermatitis diaper Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000003105 Diaper Rash Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004266 EU approved firming agent Substances 0.000 description 1
- YPZRHBJKEMOYQH-UYBVJOGSSA-L FADH2(2-) Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1COP([O-])(=O)OP([O-])(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C(NC(=O)NC2=O)=C2NC2=C1C=C(C)C(C)=C2 YPZRHBJKEMOYQH-UYBVJOGSSA-L 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- 241000234305 Hedychium Species 0.000 description 1
- 235000013717 Houttuynia Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 108010054320 Lignin peroxidase Proteins 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 206010027627 Miliaria Diseases 0.000 description 1
- 229920002821 Modacrylic Polymers 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- SAVLIIGUQOSOEP-UHFFFAOYSA-N N-octanoylglycine Chemical compound CCCCCCCC(=O)NCC(O)=O SAVLIIGUQOSOEP-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000219295 Portulaca Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000581682 Sanguisorba Species 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 241000159241 Toxicodendron Species 0.000 description 1
- 241000159243 Toxicodendron radicans Species 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 244000131415 Zanthoxylum piperitum Species 0.000 description 1
- 235000008853 Zanthoxylum piperitum Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- GXABJFOLOHUYJT-UHFFFAOYSA-N [S].OC1=CC=CC(O)=C1 Chemical compound [S].OC1=CC=CC(O)=C1 GXABJFOLOHUYJT-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229920006221 acetate fiber Polymers 0.000 description 1
- 229940100228 acetyl coenzyme a Drugs 0.000 description 1
- 229920005822 acrylic binder Polymers 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 1
- 229960002916 adapalene Drugs 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229920003180 amino resin Polymers 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000000604 anti-edema agent Substances 0.000 description 1
- 230000003656 anti-hair-loss Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 229960002255 azelaic acid Drugs 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 229940051368 capryloyl glycine Drugs 0.000 description 1
- 238000009960 carding Methods 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 229940099371 diacetylated monoglycerides Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 238000004049 embossing Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- HDERJYVLTPVNRI-UHFFFAOYSA-N ethene;ethenyl acetate Chemical group C=C.CC(=O)OC=C HDERJYVLTPVNRI-UHFFFAOYSA-N 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 150000002194 fatty esters Chemical class 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000010181 horse chestnut Nutrition 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940099563 lactobionic acid Drugs 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 239000012633 leachable Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940057867 methyl lactate Drugs 0.000 description 1
- 201000004169 miliaria rubra Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 238000011022 operating instruction Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical class OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000010204 pine bark Nutrition 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920005596 polymer binder Polymers 0.000 description 1
- 239000002491 polymer binding agent Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- IHCDKJZZFOUARO-UHFFFAOYSA-M sulfacetamide sodium Chemical compound O.[Na+].CC(=O)[N-]S(=O)(=O)C1=CC=C(N)C=C1 IHCDKJZZFOUARO-UHFFFAOYSA-M 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229960005196 titanium dioxide Drugs 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 229940068778 tocotrienols Drugs 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940045999 vitamin b 12 Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
- A61K2800/262—Transparent; Translucent
Definitions
- the present invention relates to a facial mask, and more particularly, to a facial mask having a level of transparency when exposed to a wetting agent.
- Products such as cleansers and moisturizers formulated with vitamins and other skin benefit agents have been used for many years to treat the skin.
- Employing a water-insoluble substrate such as wipe or mask to assist in the process of cleansing, moisturizing and delivery of certain benefit agents to the skin is also known.
- consumers typically use hydrating facial mask products for treatment of various skin conditions as well as to improve the physical appearance and texture of the facial skin. This can be accomplished while the user relaxes, such as in a prone position, while the mask contacts the skin of the face, and provides benefits thereto.
- a conventional facial mask spread out fully on a face will completely block the user's view of the skin. This is problematic especially for users who want to see their skin through the mask to ensure that the mask has made complete contact with the skin.
- Non-transparent masks do not allow a user to know whether there are voids or bubbles between the mask and the skin. This could give rise to uneven treatment of the face by the skin care composition contained in the mask. Such uneven treatment is especially problematic for facial masks designed to lighten or even the tone of the skin.
- conventional opaque facial masks provide undesirable aesthetics to a user who would like to be seen through the mask.
- EP 0357185 , US2004/020953 and US6998017 disclose such characteristics.
- US 6998017 relates to a method of making a three-dimensional tissue having transparent and opaque regions on a mask.
- EP 0357185 relates to a foam coated protective apparel fabric having a semi-transparent substrate.
- the facial mask comprises a water-insoluble, nonwoven substrate sized and shaped to lie against the face of a human user, wherein said substrate has an Average Wet Transparency Percentage of at least about 25% and/or a Percent Increase in Transparency of at least about 50%.
- Applicants have surprisingly found that by adjusting the composition and structure of the material from which a facial mask is made (e.g., pulp content, basis weight, etc.) a level of transparency can be produced when a wetting agent (e.g. water, micro-emulsion) is applied to the material.
- a wetting agent e.g. water, micro-emulsion
- a facial mask for treating skin comprising a water-insoluble, nonwoven substrate sized and shaped to lie against a face of a human user, wherein at least a portion of said facial mask has an Average Wet Transparency Percentage of at least about 25%, and/or a Percent Increase in Transparency of at least about 50%, is provided.
- a cosmetic method of treating facial skin by applying the above mask is provided.
- a transparent facial mask comprising a water-insoluble, nonwoven substrate.
- the facial mask has an Average Wet Transparency Percentage of at least about 25% when exposed to a wetting agent.
- the facial mask has a Percent Increase in Transparency of at least about 50%. This improved facial mask allows the user to view the surface contact between the skin and the facial mask, providing better performance by the facial mask and improved aesthetics to the user.
- the mask may be readily adapted for use on other parts of the body, or used for other applications requiring a transparent substrate.
- mixtures is meant to include a simple combination of materials and any compounds that may result from their combination.
- ingredients such as actives and other ingredients useful herein may be categorized or described by their cosmetic and/or therapeutic benefit or their postulated mode of action. However, it is to be understood that the actives and other ingredients useful herein can, in some instances, provide more than one cosmetic and/or therapeutic benefit or operate via more than one mode of action. Therefore, classifications herein are made for the sake of convenience and are not intended to limit an ingredient to the particularly stated application or applications listed.
- the facial mask comprises a water-insoluble, nonwoven substrate.
- water-insoluble means the substrate, upon immersion in distilled water at 25° C, does not readily dissolve or readily break apart. While portions of the substrate may be leachable or readily soluble in the distilled water, at least one portion of the water-insoluble substrate remains intact. For example, the intact portion may be readily manipulated, such as picked up and transported as an interconnected cohesive unit, by a user.
- the water-insoluble substrate is formed to receive or preferably retain a wetting agent (such as by absorbing the wetting agent among, along, and/or between fibers comprising the water-insoluble substrate).
- the water-insoluble substrate is capable of retaining the wetting agent from the time the product is manufactured to when the product is used by a consumer (i.e., a shelf storage period).
- the water-insoluble substrate should generally maintain its mechanical integrity such that a user can lay the water-insoluble substrate onto the skin and transfer the wetting agent thereto.
- the water-insoluble substrate is generally capable of holding portions of the wetting agent against the facial skin when used.
- FIG. 1 depicts one embodiment of a facial mask consistent with embodiments of the invention described herein.
- Facial mask 1 is generally sized and shaped to lie against the face of a user. It is preferred that the facial mask 1 lie substantially flatly against the face of the user, i.e., the facial mask 1 is capable of draping across the face and generally conforming to the curvature of the face.
- the facial mask is generally further capable of lying substantially coincident with the face of the user, i.e., it generally only requires simple manipulation such as unfolding or at most slight tearing of optional, preformed perforations in order to assume a shape that coincides with a human face.
- the facial mask is sized and shaped to lie substantially flatly against the entire face of a user.
- the facial mask is sized and shaped to extend of over and lie substantially flatly against the chin and neck of a user.
- the facial mask 1 may further comprise a vertical centerline, preferably a vertical axis of symmetry 2 that separates a left side 4 from a right side 6 of the facial mask 1. Furthermore, the facial mask 1 comprises a perimeter 3 that defines the outer boundary of the facial mask when it is laid flat such as on a tabletop.
- the facial mask 1 may include, within the perimeter 3, at least one opening.
- the opening may be pre-cut, in which case it will be visible as area devoid of water-insoluble substrate.
- the opening may be defined by a perforated or weakened line.
- the user can readily separate using little force and in a controlled fashion, the water-insoluble substrate along the perforated or weakened line. For example, a user may "punch" or “tear” the water-insoluble substrate along such a line or other shape in a controlled fashion prior to use.
- the facial mask 1 includes pre-cut openings 7 for the eyes of a user. It is further desirable that facial mask 1 include a pre-cut opening 11 for the mouth of the user.
- the facial mask may further include at least one interior slit.
- an "interior slit” is a pre-cut line in the water-insoluble material within but not touching the perimeter. Interior slits are formed by slicing the water-insoluble substrate when laid flat and are often visible only as lines or boundaries when the facial mask is laid flat.
- facial mask 1 includes one or more interior slits 13 that permit the nostril area or the mouth of the user to be exposed (for instance, uncovered) in use.
- Interior slits 13 may be straight or curved.
- one or more interior slits 13 for the nose may include a plurality of arcuate portions to facilitate adherence to the underside of a user's nasal ridge, rather than, in the case of a user with a small nose, dangling or hanging off of the nose.
- the facial mask 1 includes a forehead region 8 comprising that portion of the facial mask 1 entirely above the openings 7 for the eyes; a chin region 12 comprising that portion entirely below the opening 11 for the mouth; and a mid region 10 that includes all other portions of the facial mask 1.
- the perimeter 3 is generally of a gently curving, primarily arcuate shape that generally outlines or conforms to the shape of a typical human face.
- the perimeter 3 may also encompass various features in order to enhance the fit and comfort for users having a wide range of facial shapes and sizes.
- the facial mask may comprise of at least one separation feature.
- a separation feature is a feature defined by a perforated or weakened line that can be readily separated by the user, or a pre-cut line, in the water-insoluble substrate that touches the perimeter.
- the separation feature may, for example, be a slit, notch or wedge, or other indentation or protrusion along the perimeter having a regular or irregular shape.
- the water-insoluble substrate comprises a nonwoven material.
- non-woven means that the substrate, or a layer of the substrate, is comprised of fibers that are not woven into a fabric but rather are formed into a sheet, mat, or pad layer.
- the fibers can either be random (i.e., randomly aligned) or they can be carded (i.e., combed to be oriented in primarily one direction).
- the water-insoluble substrate can be composed of a combination of layers of random and carded fibers.
- Non-woven substrates may be comprised of a variety of natural and/or synthetic materials.
- natural it is meant that the materials are derived from plants, animals, insects, or byproducts of plants, animals, and insects.
- synthetic it is meant that the materials are obtained primarily from various man-made materials or from natural materials, which have been further altered.
- Non-limiting examples of natural materials useful in the present invention are silk fibers, keratin fibers (such as wool fibers, camel hair fibers) and cellulosic fibers (such as wood pulp fibers, cotton fibers, hemp fibers, jute fibers, and flax fibers).
- Examples of synthetic materials include, but are not limited to, those selected from the group containing acetate fibers, acrylic fibers, cellulose ester fibers, cotton fibers, modacrylic fibers, polyamide fibers, polyester fibers, polyolefin fibers, polyvinyl alcohol fibers, rayon fibers, polyurethane foam, and mixtures thereof.
- Water-insoluble substrates made from one or more of the natural and synthetic materials useful in the present invention can be obtained from a wide variety of commercial sources such as Freudenberg & Co. (Durham, NC USA), BBA Nonwovens (Nashville, TN USA), PGI Nonwovens (North Charleston, SC USA), Buckeye Technologies/Walkisoft (Memphis, TN USA), Sansho Shigyo K.K. (Tosa City, Kouchi, Japan), and Fort James Corporation (Deerfield, IL USA).
- water-insoluble substrates are also well known in the art. Such methods include, but are not limited to, air-laying, water-laying, melt-blowing, spin-bonding, or carding processes.
- the resulting substrate regardless of its method of production or composition, is then generally subjected to at least one of several types of bonding operations to anchor the individual fibers together to form a self-sustaining web.
- the water-insoluble substrate can be prepared by a variety of processes including hydro-entanglement, thermal bonding, chemical bonding and combinations of these processes.
- the water-insoluble substrate can have a single layer or multiple layers.
- a multi-layered water-insoluble substrate can include film layer(s) (e.g., aperture or non-aperture film layers) and other non-fibrous materials.
- Strength or firmness of the non-woven material may be a desirable attribute. This can be achieved, for example, by the addition of binding materials, such as wet strength resins, or the material may be made of polymer binder coatings, stable fibers, e.g. based on cotton, wool, linen and the like.
- wet strength resins include, but are not limited to, vinyl acetate-ethylene (VAE) and ethylene-vinyl chloride (EVCL) Airflex emulsions (Air Products, Lehigh, PA), Flexbond acrylic polymers (Air Products, Lehigh, PA), Rhoplex ST-954 acrylic binder (Rohm and Haas, Philadelphia, PA), and Ethylene-vinyl acetate (EVA) emulsion (DUR-O-SET® by National Starch Chemicals, Bridgewater, NJ).
- the amount of binding material in the water-insoluble substrate may range from about 5% to about 20%, by weight, of the water-substrate substrate.
- the water-insoluble substrate is flushable, i.e., the water-insoluble substrate will pass through at least 10 feet of waste pipe in two toilet flushes.
- the material may also be biodegradable.
- Non-woven materials of increased strength can also be obtained by using the so-called spunlace or hydro-entanglement technique.
- the individual fibers are twisted together so that an acceptable strength or firmness is obtained without the need to use binding materials.
- the advantage of the latter technique is the excellent softness of the non-woven material.
- the water-insoluble substrate may include a hydrogel.
- hydrogel it is meant a continuous network of polymer chains that are water-insoluble, sometimes found as a colloidal gel in which water is the dispersion medium, e.g., a multicomponent system consisting of a three-dimensional network of polymer chains and water that fills the space between macromolecules.
- the water-insoluble substrate is composed predominantly of a nonwoven fabric, a hydrogel, or combinations thereof; e.g., the water-insoluble substrate may be at least about 25% by weight (exclusive of any wetting agent) of such materials, more preferably at least about 50% by weight.
- water-insoluble substrate comprises from about 20% to about 90% by weight pulp, based on the total weight of the water-insoluble substrate.
- the fibers may be staple fibers or continuous filaments, it is preferred that the fibers are staple fibers. It has been found that such levels of pulp impart the desired transparence to the water-insoluble substrate in accordance with the invention.
- a particularly preferred pulp-containing material comprises a blend of 27% spun-bonded polypropylene, 44% pulp and 29% PET, 45 grams per square meter. It is commercially available from Orlandi SPA, Gallarate, Italy.
- the water-insoluble substrate may include thermoplastic films (e.g., polyolefin) with or without apertures.
- the water-insoluble substrate includes a stretchable or elastic material or film that is capable of fully recovering after being placed under tension of 50% or 100% strain, such as may be included for use on the laterally-extending tabs or across the entire facial mask.
- the water-insoluble material has a basis weight that may range from about 10 grams per square meter (gsm) to about 200 gsm, such as between about 30 gsm and about 120 gsm, more preferably between about 45 gsm and about 90 gsm.
- the water-insoluble substrate may have an average thickness that is less than about 1.1 mm, such as between about 0.2 mm and about 2.0 mm.
- the non-woven material may include a superabsorbent polymer.
- the term "superabsorbent polymer” refers to materials which are capable of absorbing and retaining at least about 10 times their weight in water under a 0.5 psi pressure.
- the superabsorbent polymer particles of the invention may be inorganic or organic crosslinked hydrophilic polymers, such as polyvinyl alcohols, polyethylene oxides, crosslinked starches, guar gum, xanthan gum, and other material known to the art of absorbent article manufacture.
- Additives may also be added in order to increase the softness of the water-insoluble substrate.
- additives include, but are not limited to, polyols such as glycerol, propylene glycol and polyethylene glycol, phthalate derivatives, citric esters, surfactants such as polyoxyethylene (20) sorbitan esters, and acetylated monoglycerides.
- Sensory attributes may also be incorporated into the water-insoluble substrate.
- Examples of such sensory attributes include, but are not limited to color, texture, pattern, and embossing of the water-insoluble substrate.
- the water-insoluble substrate when laid flat may cover an area that is from about 100 cm 2 to about 1000 cm 2 , such as from about 200 cm 2 to about 500 cm 2 , such as between about 200 cm 2 to about 360 cm 2 .
- Exposure of the water-insoluble substrate to a wetting agent provides transparency to the facial mask.
- the water-insoluble substrate and the wetting agent are provided separately and combined by the user just prior to or at the time of use.
- the water-insoluble substrate and the wetting agent are provided to the user already combined, for example for a period of time such as the shelf storage period or a portion thereof.
- the wetting agent is present in an amount sufficient to saturate the water-insoluble substrate and wet a user's facial skin when laid onto such skin. In another embodiment, the wetting agent is present in an amount sufficient to permit a first portion of the water-insoluble substrate to cohesively attach to a second portion of the water-insoluble substrate, wherein the first portion of the water-insoluble substrate is distant from the second portion of the water-insoluble substrate. Such cohesive attachment may be for a period of time of at least about 5 minutes when the water-insoluble substrate is laid on the face and the user face is in an upright, vertical orientation.
- the wetting agent may be used in an amount that is at least about 50% by weight of the weight of the water-insoluble substrate alone. More preferably the wetting agent is present in an amount that is at least about 75%, even more preferably at least about 85%, even more preferably at least about 200%, such as about 50% to about 5000%, for example about 200% to about 5000%, or from 50 to 300%, by weight of the weight of the water-insoluble substrate alone. This amount of wetting agent may be readily transferred to skin placed in contact with the water-insoluble substrate, as well as provide sufficient transparency to the facial mask.
- the wetting agent may be present in an amount greater than about 50% by weight, such as greater than about 65%, such as between about 65% to about 95% by weight of the water-insoluble substrate alone.
- the wetting agent may include an aqueous phase, an oily/hydrophobic phase, a gel phase, or a mixture of these phases.
- the wetting agent includes an aqueous phase, and even more preferably, the aqueous phase is an external phase (in which an oily phase or particulate phase may be dispersed, suspended or emulsified).
- the wetting agent includes an oil-in-water micro-emulsion for example comprising a polyacrylate co-polymer.
- the wetting agent has a viscosity that is less than about 5000 centipoise (cps), when measured using a Brookfield digital viscometer, Model DV-II+ Version 3.2 according to the operating instructions set forth in Manual No. M/92-161-H895, such as having a viscosity less than about 2500 cps, such as less than about 500 cps.
- cps centipoise
- the wetting agent may include solvents such as water, including those that are humectants such as glycols including glycerin or propylene glycol, or alcohols such as isopropyl alcohol or ethanol.
- the wetting agent includes water, such as in a concentration of at least about 40%, more preferably at least about 60%, and even more preferably at least about 90% by weight of the wetting agent.
- the wetting agent may include any of various ingredients known in the art of facial mask preparations, including: hydrophobic emollients such as fatty esters including esters of glycerin, fatty alcohols, hydrophobic polymeric emollients; sensory agents such as menthol and methyl lactate, chelating agents such as EDTA, preservatives such as parabens, and other conventional cosmetic adjuvants, such as dyes, opacifiers (e.g., titanium dioxide and zinc oxide), pigments, fragrances, and microcapsules, such as aminoplast microcapsules.
- hydrophobic emollients such as fatty esters including esters of glycerin, fatty alcohols, hydrophobic polymeric emollients
- sensory agents such as menthol and methyl lactate
- chelating agents such as EDTA
- preservatives such as parabens
- other conventional cosmetic adjuvants such as dyes, opacifiers (e.g.
- microcapsules are polyoxymethyene melamine urea (PMU) microcapsules, commercially available as Pontenza Dimethicone from Reed- Pacific of Dural, Austrialia.
- PMU Microcapsules 32 Micron Encapsulated Mineral Oil and Jojoba Oil, available from 3M Company of St. Paul, MN.
- At least a portion of the water-insoluble substrate has an Average Wet Transparency Percentage of at least about 25%, such as at least about 30% or preferably at least about 40%. Average Wet Transparency Percentage indicates the level of transparency of the substrate when exposed to a wetting agent.
- At least a portion of the water-insoluble substrate has Percent Increase in Transparency of at least about 50%, such as at least about 60% or preferably at least about 70%. Percent Increase in Transparency indicates the degree of change in transparency of the substrate between a dry condition and a wet condition.
- Both the Average Wet Transparency Percentage and Percent Increase in Transparency indicate the ability of the substrate to transmit light, so that objects or images underneath can be seen as if there were less or no material present.
- the device has the following parts: a light sensor, a light source, a digital output and a calibration control means.
- the light sensor and the light source are magnetic and can be coupled to form a tight seal.
- the device is calibrated prior to use to read 100% transparency.
- the light sensor portion of the device is placed on a flat surface.
- a sample of material is then placed over the light sensor.
- the light source portion of the device is then placed on top of the sample and the transparency percentage value is read. Four readings are taken for each sample, each time repositioning a different area of the sample over the sensor. The average value is then calculated.
- Average Wet Transparency Percentage is calculated by performing the above process on a sample of material saturated with a desired wetting agent. The average of the four values is the Average Wet Transparency Percentage of the material.
- Percent Increase in Transparency is obtained by performing the above process on a sample in both dry and wet conditions, and subtracting the dry average transparency value from the wet average transparency value (Average Wet Transparency Percentage) to compare the difference.
- the water-insoluble substrate or wetting agent includes one or more benefit agents.
- a “benefit agent” is a compound (e.g., a synthetic compound or a compound isolated from a natural source) that has a cosmetic or therapeutic effect on the skin including, but not limited to, lightening agents, darkening agents such as self-tanning agents, anti-acne agents, shine control agents, anti-microbial agents, antiinflammatory agents, antifungals, anti-parasite agents, external analgesics, sunscreens, photoprotectors, antioxidants, keratolytic agents, moisturizers, nutrients, vitamins, energy enhancers, anti-perspiration agents, astringents, deodorants, hair growth inhibitors, anti hair-loss agents, hair growth promoters, hair removers, skin-firming agents, anti-callous agents, anti-aging agents such as anti-wrinkle agents, skin conditioning agents, allergy inhibitors, antiseptics, external analgesics, antipruri
- the benefit agent is selected from, but not limited to, hydroxy acids, benzoyl peroxide, sulfur resorcinol, ascorbic acid and its derivatives, D-panthenol, hydroquinone, octyl methoxycinnimate, titanium dioxide, octyl salicylate, homosalate, avobenzone, polyphenolics, carotenoids, free radical scavengers, spin traps, retinoids such as retinol and retinyl palmitate, ceramides, polyunsaturated fatty acids, essential fatty acids, enzymes, enzyme inhibitors, minerals, hormones such as estrogens, steroids such as hydrocortisone, 2-dimethylaminoethanol, copper salts such as copper chloride, peptides containing copper, coenzyme Q 10, lipoic acid, amino acids such a proline and tyrosine, lipo amino acids such as capryloyl glycine and
- vitamins include, but are not limited to, vitamin A, a vitamin B such as vitamin B3, vitamin B5, and vitamin B 12, vitamin C, vitamin K, and vitamin E, and salts, esters, and derivatives thereof. (e.g., retinyl palmitate, ascorbyl acetate, and tocopherol acetate).
- hydroxy acids include, but are not limited, to glycolic acid, lactic acid, malic acid, salicylic acid, citric acid, and tartaric acid.
- antioxidants include, but are not limited to, water-soluble antioxidants such as sulfhydryl compounds and their derivatives (e.g., sodium metabisulfite and N-acetyl-cysteine), lipoic acid and dihydrolipoic acid, resveratrol, lactoferrin, and ascorbic acid and ascorbic acid derivatives (e.g., ascorbic acid glucoside, magnesium ascorbyl phosphate, and ascorbyl palmitate and ascorbyl polypeptide).
- water-soluble antioxidants such as sulfhydryl compounds and their derivatives (e.g., sodium metabisulfite and N-acetyl-cysteine), lipoic acid and dihydrolipoic acid, resveratrol, lactoferrin, and ascorbic acid and ascorbic acid derivatives (e.g., ascorbic acid glucoside, magnesium ascorbyl phosphate, and ascorbyl palmitate and ascorbyl polypeptid
- Oil-soluble antioxidants suitable for use in the compositions of this invention include, but are not limited to, butylated hydroxytoluene, retinoids (e.g., retinol and retinyl palmitate), tocopherols (e.g., tocopherol acetate), tocotrienols, and ubiquinone.
- Natural extracts containing antioxidants suitable for use in the compositions of this invention include, but not limited to, extracts containing flavonoids and isofavonoids and their derivatives (e.g., genistein and diadzein), extracts containing resveratrol and the like. Examples of such natural extracts include grape seed, green tea, pine bark, and propolis.
- botanical extracts include, but are not limited to legumes such as Soy, Aloe Vera, Feverfew, Hedychium, Rhubarb, Portulaca, Cedar Tree, Cinnamon, Witch Hazel, Dandelion, Chinese Angelica, Turmeric, Ginger, Burnet, Houttuynia, Coix Seed, and Thyme.
- legumes such as Soy, Aloe Vera, Feverfew, Hedychium, Rhubarb, Portulaca, Cedar Tree, Cinnamon, Witch Hazel, Dandelion, Chinese Angelica, Turmeric, Ginger, Burnet, Houttuynia, Coix Seed, and Thyme.
- a "botanical extract” is a blend of two or more compounds isolated from a plant.
- the benefit agent is designed for application on the forehead region and includes, but is not limited to: oil-control agents such as titanium dioxides, alcohols, botanical extracts, and talc; pore refining agents such as alpha-hydroxy acids, beta-hydroxy acids, and enzymes; anti-acne agents such as benzoyl peroxide, salicylic acid, trichlorcarban, triclosan, azelaic acid, clindamycin, adapalene, erythromycin, sodium sulfacetamide, retinoic acid, and sulfur; oil-absorbing agents such as titanium dioxides and clays; shine control agents such as silicones, alcohols, talc, and clays; dark spot reduction agents such as vitamin C, hydroquinone, botanical extracts, alpha-hydroxy acids, beta-hydroxy acids, and retinoids; and/or wrinkle/fine-line reduction agents such as retinoids, alpha-hydroxy acids, and enzymes.
- oil-control agents such as titanium dioxides, alcohols, botanical extracts, and
- the benefit agent is designed for application around the mouth and includes, but is not limited to: hydration/moisturization agents such a glycerin, silicone, glycols, botanical extracts, and esters; pore-refining agents; anti-acne agents; vasodilators such as niacinamide and horsechesnut extract; vasoconstrictors such as caffeine and botanical extracts; skin-lifting agents such as (e.g., copper containing peptides, dimethyaminoethanol, and polymers); skin-firming polymers; wrinkle/fine-line reduction agents; depigmenting/skin lightening agents such as vitamin C, hydroquinone, botanical extracts, alpha-hydroxy acids, beta-hydroxy acids, retinoids, arbutin, and kojic acid; and depilatory/hair reducing agents such as soy extracts, n-acetyl-cysteine, and isoflavones.
- hydration/moisturization agents such
- one or more benefit agents are selected from the group consisting of ascorbic acid and its derivatives, alpha-hydroxy-acids, beta-hydroxyacids, alkanolamines, proteins, enzymes, and enzyme activators, and combinations thereof are in the liquid impregnate, and one or more benefit agents are selected from the group consisting of retinoids, tocopherols, enzymes, enzyme activators, and combinations thereof are within the liquid core.
- the product comprises an enzyme such as a lignin peroxidase and a suitable activator such as a peroxide (e.g., hydrogen peroxide) as described in WO 2004/052275 .
- a peroxide e.g., hydrogen peroxide
- the facial mask is a product is in finished packaged form inside a package.
- the package is a container such as a plastic, metal or glass tube, tub, pouch or jar containing the water-insoluble substrate.
- the product may further contain additional packaging such as a plastic or cardboard box for storing one or more of such containers (e.g., a package of two to twenty individual products).
- additional packaging such as a plastic or cardboard box for storing one or more of such containers (e.g., a package of two to twenty individual products).
- Non-limiting examples of material that may be used to manufacture such containers include aluminum, polypropylene, polyethylene, and/or polyesters.
- the package is substantially air-impermeable.
- the instructions direct the user to apply the product directly to the skin.
- the instructions direct the user to apply wetting agent to the facial mask prior to application to the skin.
- the instructions direct the user to apply the product for the benefit of changing the appearance of the tone and/or color of the skin.
- the instructions may direct contacting the facial mask with the skin (e.g., the face) for a period of time, such as from about 10 seconds to about 1 hour (e.g., such as from about 1 minute to about 15 minutes).
- the user may also be directed to massage into the skin any liquid remaining on the skin after removal of the water-insoluble substrate. Such massaging may facilitate imparting improved color/tone uniformity in the skin of the subject.
- Facial masks of the present invention may be made by various conventional methods, known to those skilled in the art.
- a water-insoluble substrate such as a sheet of non-woven material optionally perforated or cut to a pre-determined size to form a "blank,” such a size and shape suitable to fit over a human face, may be formed by methods well known in the art. Openings may optionally be cut out of the blanks corresponding to the eyes, nose, and/or mouth.
- a "subtractive" method one or more separation features such as slits, notches, and wedges may be sliced, cut or punched out of the blank.
- the separation feature is formed by weakening or perforating the water-insoluble substrate rather than by slitting or removing material.
- the facial mask may be of an "integrated" structure, in that the entire facial mask is essentially uniform throughout its area, as viewed from the top in a plan view.
- the facial mask may be at least partially formed by an "additive" process, i.e., portions of the mask are stitched, bonded, or adhered together to create the separation features.
- the substrate may then be folded and placed in a plastic pouch housing or other suitable container.
- facial masks of the present invention are unitary, i.e., a one-piece mask that can be readily picked up with a user's hands and transported as single cohesive unit, and this single cohesive unit is generally adapted to cover substantially the entire face of a user.
- the facial mask may also be formed from two or more pieces. Suitable two piece mask designs with slits include a top piece that includes most or all of the forehead portion and a bottom piece that includes most or all of the chin portion.
- the wetting agent may be prepared by mixing ingredients such as water and one or other ingredients and/or more benefit agents together to form a uniform liquid.
- the resulting wetting agent may then be poured into the packaging.
- the agent may be sprayed onto or otherwise distributed in or on about the water-insoluble substrate.
- the resulting facial mask may be individually sealed in the packaging or placed along with other water-insoluble substrates together into a single package. Multiple packaged facial masks may be grouped together in an outer container, such as a box.
- a wetting agent of the present invention was prepared by combining the materials listed in Table 1 as follows. First, an oil phase was prepared by mixing and heating (40-45°C) phenoxyetol in a premix container. Then fragrance RP-2406, Dermosoft 688, Lamesoft PO 65, and Eumulgin VL 75 were added and mixed in until uniform. Second, in a separate mixture, a water phase was prepared by mixing water, Emery 917 and Hispagel 200 until the ingredients dissolved. Then Carbopol Ultrez 10 was added and mixed until uniform. The ingredients from the oil phase were then added to the water phase and mixed until uniform.
- Each sample of substrate was cut to have outer dimensions of about 6.35 cm X 7.32 cm. Where a wetting agent was used, the substrate sample was placed in a weigh boat filled with 100 grams of wetting agent for thirty seconds to saturate. Each substrate was tested under four conditions: (1) in a dry state, (2) using water as a wetting agent, (3) using the liquid from a commercially available Neutrogena® Deep Hydrating Mask as the wetting agent, and (4) using the wetting agent of Table 1. The results are shown in Table2.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
The present invention features a facial mask comprising a water-insoluble, nonwoven substrate sized and shaped to lie against the face of a human user having an Average Wet Transparency Percentage of at least about 25% and/or a Percent Increase in Transparency of at least about 50%. Methods of treating the skin using facial masks are also provided.
Description
- The present invention relates to a facial mask, and more particularly, to a facial mask having a level of transparency when exposed to a wetting agent.
- Products such as cleansers and moisturizers formulated with vitamins and other skin benefit agents have been used for many years to treat the skin. Employing a water-insoluble substrate such as wipe or mask to assist in the process of cleansing, moisturizing and delivery of certain benefit agents to the skin is also known. For example, consumers typically use hydrating facial mask products for treatment of various skin conditions as well as to improve the physical appearance and texture of the facial skin. This can be accomplished while the user relaxes, such as in a prone position, while the mask contacts the skin of the face, and provides benefits thereto.
- A conventional facial mask spread out fully on a face will completely block the user's view of the skin. This is problematic especially for users who want to see their skin through the mask to ensure that the mask has made complete contact with the skin. Non-transparent masks do not allow a user to know whether there are voids or bubbles between the mask and the skin. This could give rise to uneven treatment of the face by the skin care composition contained in the mask. Such uneven treatment is especially problematic for facial masks designed to lighten or even the tone of the skin. Furthermore, conventional opaque facial masks provide undesirable aesthetics to a user who would like to be seen through the mask.
- It is known in the art to provide some transparency in substrates. For instance,
EP 0357185 ,US2004/020953 andUS6998017 disclose such characteristics.US 6998017 relates to a method of making a three-dimensional tissue having transparent and opaque regions on a mask.EP 0357185 relates to a foam coated protective apparel fabric having a semi-transparent substrate. - Applicants have now developed a facial mask that is transparent. The facial mask comprises a water-insoluble, nonwoven substrate sized and shaped to lie against the face of a human user, wherein said substrate has an Average Wet Transparency Percentage of at least about 25% and/or a Percent Increase in Transparency of at least about 50%.
- Applicants have surprisingly found that by adjusting the composition and structure of the material from which a facial mask is made (e.g., pulp content, basis weight, etc.) a level of transparency can be produced when a wetting agent (e.g. water, micro-emulsion) is applied to the material.
-
-
FIG. 1 is a top plan view of a facial mask in accordance with the present invention. - In one aspect of the invention, a facial mask for treating skin comprising a water-insoluble, nonwoven substrate sized and shaped to lie against a face of a human user, wherein at least a portion of said facial mask has an Average Wet Transparency Percentage of at least about 25%, and/or a Percent Increase in Transparency of at least about 50%, is provided.
- In a second aspect of the invention, a cosmetic method of treating facial skin by applying the above mask is provided.
- Other features and advantages of the present invention will be apparent from the detailed description of the invention and from the claims.
- According to the present invention, a transparent facial mask is provided. In particular, the facial mask of the present invention comprises a water-insoluble, nonwoven substrate. In one embodiment of the invention, the facial mask has an Average Wet Transparency Percentage of at least about 25% when exposed to a wetting agent. In another embodiment of the invention, the facial mask has a Percent Increase in Transparency of at least about 50%. This improved facial mask allows the user to view the surface contact between the skin and the facial mask, providing better performance by the facial mask and improved aesthetics to the user.
- While the article of the present invention will be described in the context of a facial mask, the mask may be readily adapted for use on other parts of the body, or used for other applications requiring a transparent substrate.
- The phrase "mixtures" is meant to include a simple combination of materials and any compounds that may result from their combination.
- All ingredients such as actives and other ingredients useful herein may be categorized or described by their cosmetic and/or therapeutic benefit or their postulated mode of action. However, it is to be understood that the actives and other ingredients useful herein can, in some instances, provide more than one cosmetic and/or therapeutic benefit or operate via more than one mode of action. Therefore, classifications herein are made for the sake of convenience and are not intended to limit an ingredient to the particularly stated application or applications listed.
- The facial mask comprises a water-insoluble, nonwoven substrate. As used herein, "water-insoluble" means the substrate, upon immersion in distilled water at 25° C, does not readily dissolve or readily break apart. While portions of the substrate may be leachable or readily soluble in the distilled water, at least one portion of the water-insoluble substrate remains intact. For example, the intact portion may be readily manipulated, such as picked up and transported as an interconnected cohesive unit, by a user.
- The water-insoluble substrate is formed to receive or preferably retain a wetting agent (such as by absorbing the wetting agent among, along, and/or between fibers comprising the water-insoluble substrate). Preferably, the water-insoluble substrate is capable of retaining the wetting agent from the time the product is manufactured to when the product is used by a consumer (i.e., a shelf storage period). In one embodiment of the invention, during this shelf storage period the water-insoluble substrate should generally maintain its mechanical integrity such that a user can lay the water-insoluble substrate onto the skin and transfer the wetting agent thereto. Furthermore, the water-insoluble substrate is generally capable of holding portions of the wetting agent against the facial skin when used.
-
FIG. 1 depicts one embodiment of a facial mask consistent with embodiments of the invention described herein.Facial mask 1 is generally sized and shaped to lie against the face of a user. It is preferred that thefacial mask 1 lie substantially flatly against the face of the user, i.e., thefacial mask 1 is capable of draping across the face and generally conforming to the curvature of the face. The facial mask is generally further capable of lying substantially coincident with the face of the user, i.e., it generally only requires simple manipulation such as unfolding or at most slight tearing of optional, preformed perforations in order to assume a shape that coincides with a human face. In a preferred embodiment, the facial mask is sized and shaped to lie substantially flatly against the entire face of a user. As used herein, "entire face" means the majority, e.g., at least about 90%, of the face, including the nose, cheeks, around the eyes, and the forehead, as well as under and above the mouth. In another embodiment, the facial mask is sized and shaped to extend of over and lie substantially flatly against the chin and neck of a user. - The
facial mask 1 may further comprise a vertical centerline, preferably a vertical axis ofsymmetry 2 that separates aleft side 4 from aright side 6 of thefacial mask 1. Furthermore, thefacial mask 1 comprises aperimeter 3 that defines the outer boundary of the facial mask when it is laid flat such as on a tabletop. - The
facial mask 1 may include, within theperimeter 3, at least one opening. The opening may be pre-cut, in which case it will be visible as area devoid of water-insoluble substrate. Alternatively, the opening may be defined by a perforated or weakened line. In this embodiment, the user can readily separate using little force and in a controlled fashion, the water-insoluble substrate along the perforated or weakened line. For example, a user may "punch" or "tear" the water-insoluble substrate along such a line or other shape in a controlled fashion prior to use. - As shown in
FIG. 1 , thefacial mask 1 includespre-cut openings 7 for the eyes of a user. It is further desirable thatfacial mask 1 include apre-cut opening 11 for the mouth of the user. - The facial mask may further include at least one interior slit. As used herein, an "interior slit" is a pre-cut line in the water-insoluble material within but not touching the perimeter. Interior slits are formed by slicing the water-insoluble substrate when laid flat and are often visible only as lines or boundaries when the facial mask is laid flat. For example,
facial mask 1 includes one or moreinterior slits 13 that permit the nostril area or the mouth of the user to be exposed (for instance, uncovered) in use. - Interior slits 13 may be straight or curved. In one embodiment, in order to provide better fit, one or more
interior slits 13 for the nose may include a plurality of arcuate portions to facilitate adherence to the underside of a user's nasal ridge, rather than, in the case of a user with a small nose, dangling or hanging off of the nose. - The
facial mask 1 includes aforehead region 8 comprising that portion of thefacial mask 1 entirely above theopenings 7 for the eyes; achin region 12 comprising that portion entirely below theopening 11 for the mouth; and amid region 10 that includes all other portions of thefacial mask 1. - Note that the
perimeter 3 is generally of a gently curving, primarily arcuate shape that generally outlines or conforms to the shape of a typical human face. In accordance with the certain optional embodiments, theperimeter 3 may also encompass various features in order to enhance the fit and comfort for users having a wide range of facial shapes and sizes. - Specifically, in one embodiment, the facial mask may comprise of at least one separation feature. As used herein, a "separation feature" is a feature defined by a perforated or weakened line that can be readily separated by the user, or a pre-cut line, in the water-insoluble substrate that touches the perimeter. The separation feature may, for example, be a slit, notch or wedge, or other indentation or protrusion along the perimeter having a regular or irregular shape.
- The water-insoluble substrate comprises a nonwoven material. As used herein, "non-woven" means that the substrate, or a layer of the substrate, is comprised of fibers that are not woven into a fabric but rather are formed into a sheet, mat, or pad layer. The fibers can either be random (i.e., randomly aligned) or they can be carded (i.e., combed to be oriented in primarily one direction). Furthermore, the water-insoluble substrate can be composed of a combination of layers of random and carded fibers.
- Non-woven substrates may be comprised of a variety of natural and/or synthetic materials. By "natural" it is meant that the materials are derived from plants, animals, insects, or byproducts of plants, animals, and insects. By "synthetic" it is meant that the materials are obtained primarily from various man-made materials or from natural materials, which have been further altered. Non-limiting examples of natural materials useful in the present invention are silk fibers, keratin fibers (such as wool fibers, camel hair fibers) and cellulosic fibers (such as wood pulp fibers, cotton fibers, hemp fibers, jute fibers, and flax fibers).
- Examples of synthetic materials include, but are not limited to, those selected from the group containing acetate fibers, acrylic fibers, cellulose ester fibers, cotton fibers, modacrylic fibers, polyamide fibers, polyester fibers, polyolefin fibers, polyvinyl alcohol fibers, rayon fibers, polyurethane foam, and mixtures thereof.
- Water-insoluble substrates made from one or more of the natural and synthetic materials useful in the present invention can be obtained from a wide variety of commercial sources such as Freudenberg & Co. (Durham, NC USA), BBA Nonwovens (Nashville, TN USA), PGI Nonwovens (North Charleston, SC USA), Buckeye Technologies/Walkisoft (Memphis, TN USA), Sansho Shigyo K.K. (Tosa City, Kouchi, Japan), and Fort James Corporation (Deerfield, IL USA).
- Methods of making water-insoluble substrates are also well known in the art. Such methods include, but are not limited to, air-laying, water-laying, melt-blowing, spin-bonding, or carding processes. The resulting substrate, regardless of its method of production or composition, is then generally subjected to at least one of several types of bonding operations to anchor the individual fibers together to form a self-sustaining web. The water-insoluble substrate can be prepared by a variety of processes including hydro-entanglement, thermal bonding, chemical bonding and combinations of these processes. Moreover, the water-insoluble substrate can have a single layer or multiple layers. In addition, a multi-layered water-insoluble substrate can include film layer(s) (e.g., aperture or non-aperture film layers) and other non-fibrous materials.
- Strength or firmness of the non-woven material may be a desirable attribute. This can be achieved, for example, by the addition of binding materials, such as wet strength resins, or the material may be made of polymer binder coatings, stable fibers, e.g. based on cotton, wool, linen and the like. Examples of wet strength resins include, but are not limited to, vinyl acetate-ethylene (VAE) and ethylene-vinyl chloride (EVCL) Airflex emulsions (Air Products, Lehigh, PA), Flexbond acrylic polymers (Air Products, Lehigh, PA), Rhoplex ST-954 acrylic binder (Rohm and Haas, Philadelphia, PA), and Ethylene-vinyl acetate (EVA) emulsion (DUR-O-SET® by National Starch Chemicals, Bridgewater, NJ). The amount of binding material in the water-insoluble substrate may range from about 5% to about 20%, by weight, of the water-substrate substrate. In one embodiment, the water-insoluble substrate is flushable, i.e., the water-insoluble substrate will pass through at least 10 feet of waste pipe in two toilet flushes. The material may also be biodegradable.
- Non-woven materials of increased strength can also be obtained by using the so-called spunlace or hydro-entanglement technique. In this technique, the individual fibers are twisted together so that an acceptable strength or firmness is obtained without the need to use binding materials. The advantage of the latter technique is the excellent softness of the non-woven material. In another embodiment, the water-insoluble substrate may include a hydrogel. By "hydrogel" it is meant a continuous network of polymer chains that are water-insoluble, sometimes found as a colloidal gel in which water is the dispersion medium, e.g., a multicomponent system consisting of a three-dimensional network of polymer chains and water that fills the space between macromolecules.
- In one embodiment, the water-insoluble substrate is composed predominantly of a nonwoven fabric, a hydrogel, or combinations thereof; e.g., the water-insoluble substrate may be at least about 25% by weight (exclusive of any wetting agent) of such materials, more preferably at least about 50% by weight.
- In another embodiment, water-insoluble substrate comprises from about 20% to about 90% by weight pulp, based on the total weight of the water-insoluble substrate. While the fibers may be staple fibers or continuous filaments, it is preferred that the fibers are staple fibers. It has been found that such levels of pulp impart the desired transparence to the water-insoluble substrate in accordance with the invention.
- A particularly preferred pulp-containing material comprises a blend of 27% spun-bonded polypropylene, 44% pulp and 29% PET, 45 grams per square meter. It is commercially available from Orlandi SPA, Gallarate, Italy.
- Furthermore, the water-insoluble substrate may include thermoplastic films (e.g., polyolefin) with or without apertures. In one embodiment, the water-insoluble substrate includes a stretchable or elastic material or film that is capable of fully recovering after being placed under tension of 50% or 100% strain, such as may be included for use on the laterally-extending tabs or across the entire facial mask.
- In one embodiment the water-insoluble material has a basis weight that may range from about 10 grams per square meter (gsm) to about 200 gsm, such as between about 30 gsm and about 120 gsm, more preferably between about 45 gsm and about 90 gsm. The water-insoluble substrate may have an average thickness that is less than about 1.1 mm, such as between about 0.2 mm and about 2.0 mm.
- In one embodiment of the invention, the non-woven material may include a superabsorbent polymer. For the purposes of the present invention, the term "superabsorbent polymer" refers to materials which are capable of absorbing and retaining at least about 10 times their weight in water under a 0.5 psi pressure. The superabsorbent polymer particles of the invention may be inorganic or organic crosslinked hydrophilic polymers, such as polyvinyl alcohols, polyethylene oxides, crosslinked starches, guar gum, xanthan gum, and other material known to the art of absorbent article manufacture.
- Additives may also be added in order to increase the softness of the water-insoluble substrate. Examples of such additives include, but are not limited to, polyols such as glycerol, propylene glycol and polyethylene glycol, phthalate derivatives, citric esters, surfactants such as polyoxyethylene (20) sorbitan esters, and acetylated monoglycerides.
- Sensory attributes may also be incorporated into the water-insoluble substrate. Examples of such sensory attributes include, but are not limited to color, texture, pattern, and embossing of the water-insoluble substrate.
- The water-insoluble substrate when laid flat may cover an area that is from about 100 cm2 to about 1000 cm2, such as from about 200 cm2 to about 500 cm2, such as between about 200 cm2 to about 360 cm2.
- Exposure of the water-insoluble substrate to a wetting agent provides transparency to the facial mask. In one embodiment, the water-insoluble substrate and the wetting agent are provided separately and combined by the user just prior to or at the time of use. In another embodiment, the water-insoluble substrate and the wetting agent are provided to the user already combined, for example for a period of time such as the shelf storage period or a portion thereof.
- In one embodiment, the wetting agent is present in an amount sufficient to saturate the water-insoluble substrate and wet a user's facial skin when laid onto such skin. In another embodiment, the wetting agent is present in an amount sufficient to permit a first portion of the water-insoluble substrate to cohesively attach to a second portion of the water-insoluble substrate, wherein the first portion of the water-insoluble substrate is distant from the second portion of the water-insoluble substrate. Such cohesive attachment may be for a period of time of at least about 5 minutes when the water-insoluble substrate is laid on the face and the user face is in an upright, vertical orientation.
- In order to provide sufficient transparency of the water-insoluble substrate, the wetting agent may be used in an amount that is at least about 50% by weight of the weight of the water-insoluble substrate alone. More preferably the wetting agent is present in an amount that is at least about 75%, even more preferably at least about 85%, even more preferably at least about 200%, such as about 50% to about 5000%, for example about 200% to about 5000%, or from 50 to 300%, by weight of the weight of the water-insoluble substrate alone. This amount of wetting agent may be readily transferred to skin placed in contact with the water-insoluble substrate, as well as provide sufficient transparency to the facial mask. To further enhance the transfer of the wetting agent to the skin of the user, such as for a hydrating facial mask, the wetting agent may be present in an amount greater than about 50% by weight, such as greater than about 65%, such as between about 65% to about 95% by weight of the water-insoluble substrate alone.
- The wetting agent may include an aqueous phase, an oily/hydrophobic phase, a gel phase, or a mixture of these phases. In one desirable embodiment, the wetting agent includes an aqueous phase, and even more preferably, the aqueous phase is an external phase (in which an oily phase or particulate phase may be dispersed, suspended or emulsified). In another desirable embodiment, the wetting agent includes an oil-in-water micro-emulsion for example comprising a polyacrylate co-polymer.
- In one embodiment, the wetting agent has a viscosity that is less than about 5000 centipoise (cps), when measured using a Brookfield digital viscometer, Model DV-II+ Version 3.2 according to the operating instructions set forth in Manual No. M/92-161-H895, such as having a viscosity less than about 2500 cps, such as less than about 500 cps. Such low viscosity wetting agents tend to be aesthetically pleasing to the user.
- The wetting agent may include solvents such as water, including those that are humectants such as glycols including glycerin or propylene glycol, or alcohols such as isopropyl alcohol or ethanol. In one preferred embodiment, the wetting agent includes water, such as in a concentration of at least about 40%, more preferably at least about 60%, and even more preferably at least about 90% by weight of the wetting agent.
- The wetting agent may include any of various ingredients known in the art of facial mask preparations, including: hydrophobic emollients such as fatty esters including esters of glycerin, fatty alcohols, hydrophobic polymeric emollients; sensory agents such as menthol and methyl lactate, chelating agents such as EDTA, preservatives such as parabens, and other conventional cosmetic adjuvants, such as dyes, opacifiers (e.g., titanium dioxide and zinc oxide), pigments, fragrances, and microcapsules, such as aminoplast microcapsules. One particular example of suitable microcapsules are polyoxymethyene melamine urea (PMU) microcapsules, commercially available as Pontenza Dimethicone from Reed-Pacific of Dural, Austrialia. Another such example is PMU Microcapsules (32 Micron Encapsulated Mineral Oil and Jojoba Oil), available from 3M Company of St. Paul, MN.
- According to one embodiment of the invention, at least a portion of the water-insoluble substrate has an Average Wet Transparency Percentage of at least about 25%, such as at least about 30% or preferably at least about 40%. Average Wet Transparency Percentage indicates the level of transparency of the substrate when exposed to a wetting agent.
- In another embodiment of the invention, at least a portion of the water-insoluble substrate has Percent Increase in Transparency of at least about 50%, such as at least about 60% or preferably at least about 70%. Percent Increase in Transparency indicates the degree of change in transparency of the substrate between a dry condition and a wet condition.
- Both the Average Wet Transparency Percentage and Percent Increase in Transparency indicate the ability of the substrate to transmit light, so that objects or images underneath can be seen as if there were less or no material present.
- Average Wet Transparency Percentage and Percent Increase in Transparency may be measured using a SwissTester Transparency Measuring Device. The device has the following parts: a light sensor, a light source, a digital output and a calibration control means. The light sensor and the light source are magnetic and can be coupled to form a tight seal. The device is calibrated prior to use to read 100% transparency. The light sensor portion of the device is placed on a flat surface. A sample of material is then placed over the light sensor. The light source portion of the device is then placed on top of the sample and the transparency percentage value is read. Four readings are taken for each sample, each time repositioning a different area of the sample over the sensor. The average value is then calculated.
- Average Wet Transparency Percentage is calculated by performing the above process on a sample of material saturated with a desired wetting agent. The average of the four values is the Average Wet Transparency Percentage of the material.
- Percent Increase in Transparency is obtained by performing the above process on a sample in both dry and wet conditions, and subtracting the dry average transparency value from the wet average transparency value (Average Wet Transparency Percentage) to compare the difference.
- In one embodiment of the invention, the water-insoluble substrate or wetting agent includes one or more benefit agents. What is meant by a "benefit agent" is a compound (e.g., a synthetic compound or a compound isolated from a natural source) that has a cosmetic or therapeutic effect on the skin including, but not limited to, lightening agents, darkening agents such as self-tanning agents, anti-acne agents, shine control agents, anti-microbial agents, antiinflammatory agents, antifungals, anti-parasite agents, external analgesics, sunscreens, photoprotectors, antioxidants, keratolytic agents, moisturizers, nutrients, vitamins, energy enhancers, anti-perspiration agents, astringents, deodorants, hair growth inhibitors, anti hair-loss agents, hair growth promoters, hair removers, skin-firming agents, anti-callous agents, anti-aging agents such as anti-wrinkle agents, skin conditioning agents, allergy inhibitors, antiseptics, external analgesics, antipruritics, antihistamines, antiinfectives, anticholinergics, vasoconstrictors, vasodilators, wound-healing promoters, peptides, polypeptides, proteins, deodorants, anti-perspirants, film-forming polymers, counterirritants, enzymes, enzyme inhibitors, poison ivy treatment agents, poison oak treatment agent, burn treatment agents; anti-diaper rash treatment agents; prickly heat agents; herbal extracts; flavenoids; sensates; antioxidants, keratolytics; sunscreens; and anti-edema agents; and combinations thereof.
- In one embodiment of the invention, the benefit agent is selected from, but not limited to, hydroxy acids, benzoyl peroxide, sulfur resorcinol, ascorbic acid and its derivatives, D-panthenol, hydroquinone, octyl methoxycinnimate, titanium dioxide, octyl salicylate, homosalate, avobenzone, polyphenolics, carotenoids, free radical scavengers, spin traps, retinoids such as retinol and retinyl palmitate, ceramides, polyunsaturated fatty acids, essential fatty acids, enzymes, enzyme inhibitors, minerals, hormones such as estrogens, steroids such as hydrocortisone, 2-dimethylaminoethanol, copper salts such as copper chloride, peptides containing copper,
coenzyme Q 10, lipoic acid, amino acids such a proline and tyrosine, lipo amino acids such as capryloyl glycine and sarcosine, vitamins, lactobionic acid, acetyl-coenzyme A, niacin, riboflavin, thiamin, ribose, electron transporters such as NADH and FADH2, and other botanical extracts, and salt, esters, and derivatives thereof. The benefit agent will typically be present in an amount of from about 0.001% to about 20% by weight of the liquid impregnate, e.g., about 0.0 1 % to about 10% such as about 0.1 % to about 5%. - Examples of vitamins include, but are not limited to, vitamin A, a vitamin B such as vitamin B3, vitamin B5, and
vitamin B 12, vitamin C, vitamin K, and vitamin E, and salts, esters, and derivatives thereof. (e.g., retinyl palmitate, ascorbyl acetate, and tocopherol acetate). Examples of hydroxy acids include, but are not limited, to glycolic acid, lactic acid, malic acid, salicylic acid, citric acid, and tartaric acid. - Examples of antioxidants include, but are not limited to, water-soluble antioxidants such as sulfhydryl compounds and their derivatives (e.g., sodium metabisulfite and N-acetyl-cysteine), lipoic acid and dihydrolipoic acid, resveratrol, lactoferrin, and ascorbic acid and ascorbic acid derivatives (e.g., ascorbic acid glucoside, magnesium ascorbyl phosphate, and ascorbyl palmitate and ascorbyl polypeptide). Oil-soluble antioxidants suitable for use in the compositions of this invention include, but are not limited to, butylated hydroxytoluene, retinoids (e.g., retinol and retinyl palmitate), tocopherols (e.g., tocopherol acetate), tocotrienols, and ubiquinone. Natural extracts containing antioxidants suitable for use in the compositions of this invention, include, but not limited to, extracts containing flavonoids and isofavonoids and their derivatives (e.g., genistein and diadzein), extracts containing resveratrol and the like. Examples of such natural extracts include grape seed, green tea, pine bark, and propolis.
- Examples of botanical extracts include, but are not limited to legumes such as Soy, Aloe Vera, Feverfew, Hedychium, Rhubarb, Portulaca, Cedar Tree, Cinnamon, Witch Hazel, Dandelion, Chinese Angelica, Turmeric, Ginger, Burnet, Houttuynia, Coix Seed, and Thyme. What is meant by a "botanical extract" is a blend of two or more compounds isolated from a plant.
- In one embodiment of the invention, the benefit agent is designed for application on the forehead region and includes, but is not limited to: oil-control agents such as titanium dioxides, alcohols, botanical extracts, and talc; pore refining agents such as alpha-hydroxy acids, beta-hydroxy acids, and enzymes; anti-acne agents such as benzoyl peroxide, salicylic acid, trichlorcarban, triclosan, azelaic acid, clindamycin, adapalene, erythromycin, sodium sulfacetamide, retinoic acid, and sulfur; oil-absorbing agents such as titanium dioxides and clays; shine control agents such as silicones, alcohols, talc, and clays; dark spot reduction agents such as vitamin C, hydroquinone, botanical extracts, alpha-hydroxy acids, beta-hydroxy acids, and retinoids; and/or wrinkle/fine-line reduction agents such as retinoids, alpha-hydroxy acids, and enzymes.
- In another embodiment of the invention, the benefit agent is designed for application around the mouth and includes, but is not limited to: hydration/moisturization agents such a glycerin, silicone, glycols, botanical extracts, and esters; pore-refining agents; anti-acne agents; vasodilators such as niacinamide and horsechesnut extract; vasoconstrictors such as caffeine and botanical extracts; skin-lifting agents such as (e.g., copper containing peptides, dimethyaminoethanol, and polymers); skin-firming polymers; wrinkle/fine-line reduction agents; depigmenting/skin lightening agents such as vitamin C, hydroquinone, botanical extracts, alpha-hydroxy acids, beta-hydroxy acids, retinoids, arbutin, and kojic acid; and depilatory/hair reducing agents such as soy extracts, n-acetyl-cysteine, and isoflavones.
- While various combinations are contemplated, under one non-limiting example, one or more benefit agents are selected from the group consisting of ascorbic acid and its derivatives, alpha-hydroxy-acids, beta-hydroxyacids, alkanolamines, proteins, enzymes, and enzyme activators, and combinations thereof are in the liquid impregnate, and one or more benefit agents are selected from the group consisting of retinoids, tocopherols, enzymes, enzyme activators, and combinations thereof are within the liquid core.
- In one embodiment of the invention, the product comprises an enzyme such as a lignin peroxidase and a suitable activator such as a peroxide (e.g., hydrogen peroxide) as described in
WO 2004/052275 . - In one embodiment of the invention, the facial mask is a product is in finished packaged form inside a package. In one embodiment, the package is a container such as a plastic, metal or glass tube, tub, pouch or jar containing the water-insoluble substrate. The product may further contain additional packaging such as a plastic or cardboard box for storing one or more of such containers (e.g., a package of two to twenty individual products). Non-limiting examples of material that may be used to manufacture such containers include aluminum, polypropylene, polyethylene, and/or polyesters. In one embodiment of the invention, the package is substantially air-impermeable.
- In one embodiment, where the water-insoluble substrate contains a wetting agent that is present in an amount of at least about 75% by weight of the weight of the water-insoluble substrate, the instructions direct the user to apply the product directly to the skin. In another embodiment where the water-insoluble substrate contains a wetting agent that is present in an amount less than about 75% by weight of the weight of the water-insoluble substrate or the product does not contain any wetting agent, the instructions direct the user to apply wetting agent to the facial mask prior to application to the skin.
- In one embodiment, the instructions direct the user to apply the product for the benefit of changing the appearance of the tone and/or color of the skin.
- The instructions may direct contacting the facial mask with the skin (e.g., the face) for a period of time, such as from about 10 seconds to about 1 hour (e.g., such as from about 1 minute to about 15 minutes). The user may also be directed to massage into the skin any liquid remaining on the skin after removal of the water-insoluble substrate. Such massaging may facilitate imparting improved color/tone uniformity in the skin of the subject.
- Facial masks of the present invention may be made by various conventional methods, known to those skilled in the art. For example, a water-insoluble substrate, such as a sheet of non-woven material optionally perforated or cut to a pre-determined size to form a "blank," such a size and shape suitable to fit over a human face, may be formed by methods well known in the art. Openings may optionally be cut out of the blanks corresponding to the eyes, nose, and/or mouth. Using a "subtractive" method one or more separation features such as slits, notches, and wedges may be sliced, cut or punched out of the blank. In one embodiment, the separation feature is formed by weakening or perforating the water-insoluble substrate rather than by slitting or removing material. Consistent with these embodiments, the facial mask may be of an "integrated" structure, in that the entire facial mask is essentially uniform throughout its area, as viewed from the top in a plan view.
- In an alternative embodiment, the facial mask may be at least partially formed by an "additive" process, i.e., portions of the mask are stitched, bonded, or adhered together to create the separation features. After forming the water-insoluble substrate, the substrate may then be folded and placed in a plastic pouch housing or other suitable container.
- It is generally preferred that facial masks of the present invention are unitary, i.e., a one-piece mask that can be readily picked up with a user's hands and transported as single cohesive unit, and this single cohesive unit is generally adapted to cover substantially the entire face of a user. However, the facial mask may also be formed from two or more pieces. Suitable two piece mask designs with slits include a top piece that includes most or all of the forehead portion and a bottom piece that includes most or all of the chin portion.
- The wetting agent may be prepared by mixing ingredients such as water and one or other ingredients and/or more benefit agents together to form a uniform liquid. The resulting wetting agent may then be poured into the packaging. Alternatively, the agent may be sprayed onto or otherwise distributed in or on about the water-insoluble substrate.
- The resulting facial mask may be individually sealed in the packaging or placed along with other water-insoluble substrates together into a single package. Multiple packaged facial masks may be grouped together in an outer container, such as a box.
- The following examples illustrate details of embodiments of the invention, without limiting it in any matter.
- A wetting agent of the present invention was prepared by combining the materials listed in Table 1 as follows. First, an oil phase was prepared by mixing and heating (40-45°C) phenoxyetol in a premix container. Then fragrance RP-2406, Dermosoft 688, Lamesoft PO 65, and Eumulgin VL 75 were added and mixed in until uniform. Second, in a separate mixture, a water phase was prepared by mixing water, Emery 917 and Hispagel 200 until the ingredients dissolved. Then
Carbopol Ultrez 10 was added and mixed until uniform. The ingredients from the oil phase were then added to the water phase and mixed until uniform. Then 30% sodium hydroxide solution, Sodium Benzoate Dense NF/FCC and 20% Citric Acid solution were added and mixed until uniform.Table 1 Ingredient %W/W Phenoxyetol 0.600 Fragrance RP-2406 0.100 Dermosoft 688 0.060 Lamesoft PO 65 0.250 Eumulgin VL 75 0.250 Purified Water 97.260 Emery 917 0.180 Hispagel 200 0.200 Carbopol Ultrez 100.200 30% sodium hydroxide solution 0.200 Sodium Benzoate Dense NF/FCC 0.500 20% Citric Acid 0.200 - A series of substrates were measured for Average Wet Transparency Percentage and Percent Increase in Transparency using the method described above as follows.
- Each sample of substrate was cut to have outer dimensions of about 6.35 cm X 7.32 cm. Where a wetting agent was used, the substrate sample was placed in a weigh boat filled with 100 grams of wetting agent for thirty seconds to saturate. Each substrate was tested under four conditions: (1) in a dry state, (2) using water as a wetting agent, (3) using the liquid from a commercially available Neutrogena® Deep Hydrating Mask as the wetting agent, and (4) using the wetting agent of Table 1. The results are shown in Table2.
Table 2 SUBSTRATE WETTING AGENT Trial 1 Trial 2 Trial 3 Trial 4 AVERAGE WET TRANSPARENCY PERCENTAGE PERCENT INCREASE IN TRANSPARENCY 45 GSM (27% Polypropylene, 44% Pulp, 29% PET) None 16.2 16.2 15.7 16.3 16.1 45 GSM (27% Polypropylene, 44% Pulp, 29% PET) Water 25.7 25.0 26.6 24.7 25.5 58.4 45 GSM (27% Polypropylene, 44% Pulp, 29% PET) Neutrogena® Deep Hydrating Mask liquid 20.8 20.9 20.4 20.3 20.6 28.0 45 GSM (27% Polypropylene, 44% Pulp, 29% PET) Table 1 Wetting Agent 26.4 26.3 26.0 25.7 26.1 62.1 80 GSM (27% Polypropylene, 44% Pulp, 29% PET) None 8.9 9.0 8.9 9.0 9.0 80 GSM (27% Polypropylene, 44% Pulp, 29% PET) Water 18.7 18.6 18.2 18.6 18.5 107.0 80 GSM (27% Polypropylene, 44% Pulp, 29% PET) Neutrogena® Deep Hydrating Mask liquid 16.3 16.5 16.7 16.9 16.6 85.5 80 GSM (27% Polypropylene, 44% Pulp, 29% PET) Table 1 Wetting Agent 17.0 16.3 16.2 16.4 16.5 84.1 (55% Pulp, 35% Rayon, 10% PET) 75 GSM None 9.7 9.1 9.4 8.5 9.2 (55% Pulp, 35% Rayon, 10% PET) 75 GSM Water 17.2 17.6 17.5 17.2 17.4 89.4 (55% Pulp, 35% Rayon, 10% PET) 75 GSM Neutrogena® Deep Hydrating Mask liquid 17.8 18.2 19.0 18.3 18.3 99.7 (55% Pulp, 35% Rayon, 10% PET) 75 GSM Table 1 Wetting Agent 21.3 19.3 20.5 18.0 19.8 115.5 Airlaid 95 GSM (80% Pulp) None 8.0 8.2 8.4 8.1 8.2 Airlaid 95 GSM (80% Pulp) Water 18.8 18.6 18.0 18.4 18.5 125.7 Airlaid 95 GSM (80% Pulp) Neutrogena® Deep Hydrating Mask liquid 16.9 16.0 16.7 16.6 16.6 102.4 Airlaid 95 GSM (80% Pulp) Table 1 Wetting Agent 17.5 18.5 17.2 17.4 17.7 115.9 (60% Viscose, 40% PET) 50 GSM-microcreped None 13.8 14.0 14.0 14.5 14.1 (60% Viscose, 40% PET) 50 GSM-microcreped Water 18.4 19.7 18.7 18.4 18.8 33.6 (60% Viscose, 40% PET) 50 GSM-microcreped Neutrogena® Deep Hydrating Mask liquid 19.1 17.9 19.2 18.1 18.6 32.0 (60% Viscose, 40% PET) 50 GSM-microcreped Table 1 Wetting Agent 17.8 18.6 18.7 17.0 18.0 28.1 Spunlace (40% Viscose, 60% PET) 50 GSM None 19.4 20.8 18.5 18.4 19.3 Spunlace (40% Viscose, 60% PET) 50 GSM Water 22.8 23.7 24.0 24.6 23.8 23.3 Spunlace (40% Viscose, 60% PET) 50 GSM Neutrogena® Deep Hydrating Mask liquid 18.2 18.1 18.5 18.5 18.3 -4.9 Spunlace (40% Viscose, 60% PET) 50 GSM Table 1 Wetting Agent 20.6 22.5 21.5 22.3 21.7 12.7 (40% PET, 60% Rayon) 45 GSM None 16.0 15.9 17.7 16.7 16.6 (40% PET, 60% Rayon) 45 GSM Water 22.0 20.7 19.5 21.1 20.8 25.6 (40% PET, 60% Rayon) 45 GSM Neutrogena® Deep Hydrating Mask liquid 22.1 22.1 21.7 22.9 22.2 33.9 (40% PET, 60% Rayon) 45 GSM Table 1 Wetting Agent 21.1 25.5 24.6 22.2 23.4 40.9 (60% PET, 40% Rayon) 45 GSM None 19.9 20.3 21.2 20.5 20.4 (60% PET, 40% Rayon) 45 GSM Water 21.6 23.7 25.1 24.8 23.8 16.24 (60% PET, 40% Rayon) 45 GSM Neutrogena® Deep Hydrating Mask liquid 23.8 24.4 25.3 23.1 24.1 17.95 (60% PET, 40% Rayon) 45 GSM Table 1 Wetting Agent 23.9 24.6 24.4 26.5 24.8 21.37 (60 PET, 40% RAYON) 52 GSM - microcreped None 13.2 11.8 13.5 13.2 12.9 (60 PET, 40% RAYON) 52 GSM - microcreped Water 18.7 19.2 19.2 18.9 19.0 47.0 (60 PET, 40% RAYON) 52 GSM - microcreped Neutrogena® Deep Hydrating Mask liquid 19.6 19.0 19.5 19.7 19.5 50.5 (60 PET, 40% RAYON) 52 GSM - microcreped Table 1 Wetting Agent 20.8 17.9 19.1 18.8 19.2 48.2 (60% PET, 40%Rayon) 52 GSM-hydroembossed None 18.6 18.9 20.0 17.8 18.8 (60% PET, 40% Rayon) 52 GSM-hydroembossed Water 24.0 24.6 25.0 24.8 24.6 30.7 (60% PET, 40% Rayon) 52 GSM-hydroembossed Neutrogena® Deep Hydrating Mask liquid 20.2 17.7 23.4 20.1 20.4 8.1 (60% PET, 40% Rayon) 52 GSM-hydroembossed Table 1 Wettir Agent 23.9 22.6 22.0 21.4 22.5 19.4 - It is understood that while the invention has been described in conjunction with the detailed description thereof, that the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are within the claims.
Claims (9)
- A facial mask for treating skin, comprising a water-insoluble, nonwoven substrate sized and shaped to lie against a face of a human user, wherein at least a portion of said water-insoluble substrate has an Average Wet Transparency Percentage of at least about 25%, and/or a Percent Increase in Transparency of at least about 50%.
- The facial mask according to claim 1, wherein said water-insoluble substrate comprises a web selected from hydro-entangled nonwoven web, thermal bond nonwoven web, chemically-bonded dry-formed nonwoven web, or combinations thereof.
- The facial mask according to claim 2, wherein said water-insoluble substrate comprises from about 20% to about 95% by weight of pulp based on the weight of said water-insoluble substrate.
- The facial mask according to any preceding claim, wherein said wetting agent is an oil-in-water emulsion.
- The facial mask according to claim 4, wherein said emulsion is combined with said water-insoluble substrate in an amount of about 50% to about 5000% or from about 50% to about 300% by weight based on the weight of said water-insoluble substrate alone.
- The facial mask according to any preceding claim, wherein said water-insoluble substrate has a basis weight of about 10 gsm to about 200 gsm.
- The facial mask of any preceding claim, wherein said water-insoluble substrate further comprises openings for the eyes and mouth of the user.
- The facial mask of any preceding claim, wherein said water-insoluble substrate and said wetting agent are packaged together.
- A cosmetic method of treating facial skin, comprising applying to said skin a facial mask according to any one of claims 1 to 7.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/643,245 US20110152795A1 (en) | 2009-12-21 | 2009-12-21 | Transparent facial treatment mask |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2384734A2 true EP2384734A2 (en) | 2011-11-09 |
Family
ID=43797521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP10252172A Withdrawn EP2384734A2 (en) | 2009-12-21 | 2010-12-20 | Transparent facial treatment mask |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20110152795A1 (en) |
| EP (1) | EP2384734A2 (en) |
| KR (1) | KR20110073332A (en) |
| CN (1) | CN102100640A (en) |
| BR (1) | BRPI1005658A2 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013076238A1 (en) * | 2011-11-25 | 2013-05-30 | L'oreal | Composition comprising a superabsorbent polymer and a nonsuperabsorbent acrylic acid homopolymer or copolymer which is at least partially neutralized |
| WO2018158416A1 (en) | 2017-03-03 | 2018-09-07 | Kelheim Fibres Gmbh | Use of a viscose fiber |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5518352B2 (en) * | 2008-04-15 | 2014-06-11 | 株式会社ニチエイ | 3D face mask |
| US9475709B2 (en) | 2010-08-25 | 2016-10-25 | Lockheed Martin Corporation | Perforated graphene deionization or desalination |
| FR2984134B1 (en) * | 2011-12-16 | 2014-05-16 | Oreal | COSMETIC COMPOSITION COMPRISING A SUPERABSORBENT POLYMER AND A MINERAL, LAMELLAR OR PLATELET CHARGE, MATIFIANT |
| US9032554B2 (en) * | 2012-03-29 | 2015-05-19 | Cary M Lucier | Mask |
| US10653824B2 (en) | 2012-05-25 | 2020-05-19 | Lockheed Martin Corporation | Two-dimensional materials and uses thereof |
| US9844757B2 (en) | 2014-03-12 | 2017-12-19 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
| US9834809B2 (en) | 2014-02-28 | 2017-12-05 | Lockheed Martin Corporation | Syringe for obtaining nano-sized materials for selective assays and related methods of use |
| US10118130B2 (en) | 2016-04-14 | 2018-11-06 | Lockheed Martin Corporation | Two-dimensional membrane structures having flow passages |
| US10418143B2 (en) | 2015-08-05 | 2019-09-17 | Lockheed Martin Corporation | Perforatable sheets of graphene-based material |
| US9610546B2 (en) | 2014-03-12 | 2017-04-04 | Lockheed Martin Corporation | Separation membranes formed from perforated graphene and methods for use thereof |
| US9744617B2 (en) | 2014-01-31 | 2017-08-29 | Lockheed Martin Corporation | Methods for perforating multi-layer graphene through ion bombardment |
| CN104487629B (en) * | 2012-06-12 | 2018-01-30 | 可乐丽可乐富丽世股份有限公司 | Lotion Sheets & Masks |
| US9394637B2 (en) | 2012-12-13 | 2016-07-19 | Jacob Holm & Sons Ag | Method for production of a hydroentangled airlaid web and products obtained therefrom |
| WO2014164621A1 (en) | 2013-03-12 | 2014-10-09 | Lockheed Martin Corporation | Method for forming filter with uniform aperture size |
| US9572918B2 (en) | 2013-06-21 | 2017-02-21 | Lockheed Martin Corporation | Graphene-based filter for isolating a substance from blood |
| SG11201606289RA (en) | 2014-01-31 | 2016-08-30 | Lockheed Corp | Perforating two-dimensional materials using broad ion field |
| SG11201606287VA (en) | 2014-01-31 | 2016-08-30 | Lockheed Corp | Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer |
| EA201790508A1 (en) | 2014-09-02 | 2017-08-31 | Локхид Мартин Корпорейшн | HEMODIALYSIS AND HEMOPHILTRATION MEMBRANES BASED ON TWO-DIMENSIONAL MEMBRANE MATERIAL AND METHODS OF THEIR APPLICATION |
| MX394677B (en) | 2014-10-31 | 2025-03-24 | Lubrizol Advanced Mat Inc | THERMOPLASTIC POLYURETHANE FILM FOR THE RELEASE OF ACTIVE AGENTS TO SKIN SURFACES. |
| KR20180037991A (en) | 2015-08-06 | 2018-04-13 | 록히드 마틴 코포레이션 | Deformation and perforation of graphene nanoparticles |
| WO2017180134A1 (en) | 2016-04-14 | 2017-10-19 | Lockheed Martin Corporation | Methods for in vivo and in vitro use of graphene and other two-dimensional materials |
| KR20190019907A (en) | 2016-04-14 | 2019-02-27 | 록히드 마틴 코포레이션 | Handling graphene sheets for large-scale transport using the free-floating method |
| KR20190018411A (en) | 2016-04-14 | 2019-02-22 | 록히드 마틴 코포레이션 | Selective interface relaxation of graphene defects |
| SG11201808961QA (en) | 2016-04-14 | 2018-11-29 | Lockheed Corp | Methods for in situ monitoring and control of defect formation or healing |
| WO2017180135A1 (en) | 2016-04-14 | 2017-10-19 | Lockheed Martin Corporation | Membranes with tunable selectivity |
| GB2561180A (en) * | 2017-04-03 | 2018-10-10 | Pz Cussons Beauty Llp | Cosmetic Mask |
| JP6680950B2 (en) | 2017-04-07 | 2020-04-15 | 旭化成株式会社 | Cellulose non-woven fabric having a consolidated part |
| CN108635239A (en) * | 2018-07-27 | 2018-10-12 | 苏州人本药业有限公司 | A kind of separate type sheet-type packs and application method up and down |
| KR20230004978A (en) | 2021-06-30 | 2023-01-09 | 주식회사 블리스팩 | Multi-layer skin beauty patch and facial mask |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0357185A2 (en) | 1988-09-02 | 1990-03-07 | Precision Fabrics Group, Inc. | Foam coated protective apparel fabric |
| US20040020953A1 (en) | 2002-08-02 | 2004-02-05 | Ed Kopidlansky | Motorcycle luggage rack system |
| WO2004052275A2 (en) | 2002-12-12 | 2004-06-24 | R.B.T. (Rakuto Bio Technologies) Ltd. | Methods of producing lignin peroxidase and its use in skin and hair lightening |
| US6998017B2 (en) | 2000-11-03 | 2006-02-14 | Kimberly-Clark Worldwide, Inc. | Methods of making a three-dimensional tissue |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050013784A1 (en) * | 2001-02-08 | 2005-01-20 | The Procter & Gamble Company | Mask composition |
| US20030167556A1 (en) * | 2002-03-05 | 2003-09-11 | Consumers Choice Systems, Inc. | Methods and devices for transdermal delivery of anti-aging compounds for treatment and prevention of facial or neck skin aging |
| US6702792B2 (en) * | 2002-07-18 | 2004-03-09 | Kenji Nakamura | Face mask having excellent usability |
| US20040209539A1 (en) * | 2003-04-15 | 2004-10-21 | Philip Confalone | High opacity nonwoven binder composition |
| US6974470B2 (en) * | 2004-02-27 | 2005-12-13 | Kao Corporation | Heat-generative, steam generation sheet for face |
| KR20120065434A (en) * | 2006-07-14 | 2012-06-20 | 더 프록터 앤드 갬블 캄파니 | Treatment articles capable of delivering intensive care and overall treatment simultaneously |
-
2009
- 2009-12-21 US US12/643,245 patent/US20110152795A1/en not_active Abandoned
-
2010
- 2010-12-20 EP EP10252172A patent/EP2384734A2/en not_active Withdrawn
- 2010-12-21 KR KR1020100131480A patent/KR20110073332A/en not_active Withdrawn
- 2010-12-21 CN CN2010106180832A patent/CN102100640A/en active Pending
- 2010-12-21 BR BRPI1005658-0A patent/BRPI1005658A2/en not_active Application Discontinuation
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0357185A2 (en) | 1988-09-02 | 1990-03-07 | Precision Fabrics Group, Inc. | Foam coated protective apparel fabric |
| US6998017B2 (en) | 2000-11-03 | 2006-02-14 | Kimberly-Clark Worldwide, Inc. | Methods of making a three-dimensional tissue |
| US20040020953A1 (en) | 2002-08-02 | 2004-02-05 | Ed Kopidlansky | Motorcycle luggage rack system |
| WO2004052275A2 (en) | 2002-12-12 | 2004-06-24 | R.B.T. (Rakuto Bio Technologies) Ltd. | Methods of producing lignin peroxidase and its use in skin and hair lightening |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013076238A1 (en) * | 2011-11-25 | 2013-05-30 | L'oreal | Composition comprising a superabsorbent polymer and a nonsuperabsorbent acrylic acid homopolymer or copolymer which is at least partially neutralized |
| FR2983071A1 (en) * | 2011-11-25 | 2013-05-31 | Oreal | COMPOSITION COMPRISING A SUPERABSORBENT POLYMER AND A NON-SUPERABSORBENT ACRYLIC ACIDIC ACID HOMO- OR COPOLYMER AND AT LEAST PARTIALLY NEUTRALIZED |
| WO2018158416A1 (en) | 2017-03-03 | 2018-09-07 | Kelheim Fibres Gmbh | Use of a viscose fiber |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102100640A (en) | 2011-06-22 |
| US20110152795A1 (en) | 2011-06-23 |
| KR20110073332A (en) | 2011-06-29 |
| BRPI1005658A2 (en) | 2012-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2384734A2 (en) | Transparent facial treatment mask | |
| EP2113282B1 (en) | Facial mask | |
| CA2502391C (en) | Product for treating the skin | |
| EP2213197A1 (en) | Facial treatment mask comprising an isolation layer | |
| CN104814595B (en) | With the foaming Porous Pad For Use that electric device is used together | |
| CA2585398A1 (en) | Treatment articles capable of conforming to an underlying shape | |
| KR20090104780A (en) | Face mask | |
| WO2020108733A1 (en) | Wet wipes for cleansing and moisturizing of the skin | |
| US20050074484A1 (en) | Product for administration of active agents to different areas of the skin | |
| TW201141701A (en) | Transparent facial treatment mask | |
| WO2000056277A1 (en) | Cosmetic towelettes | |
| HK1147430A (en) | Facial treatment mask comprising an isolation layer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
| 18W | Application withdrawn |
Effective date: 20121213 |